Clinical trial
The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis
NCT00493415 · Frisius Medisch Centrum, Other · Completed
Key facts
| NCT number | NCT00493415 |
|---|---|
| Title | The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis |
| Official title | The Evaluation of the Effect of Nitroglycerine Versus Placebo on the Microcirculation by Means of SDF Imaging in Septic Patients on the ICU |
| Acronym | NISMIS |
| Lead sponsor | Frisius Medisch Centrum, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sepsis, Septic Shock |
| Intervention type | Drug |
| Interventions | nitroglycerin iv, placebo = nacl 0.9% |
| Enrollment | 70 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 28, 2007 |
| Last update posted | Jul 16, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: